Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer
Lesley-Ann Martin, Giles L. S. Davies, Marion T. Weigel, Nadine Betambeau, Margaret J. Hills, Janine Salter, Geraldine Walsh, Roger A'Hern, Mitch Dowsett
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.